We are live on ! Find out more
REVB icon

Revelation Biosciences

12 hedge funds and large institutions have $241K invested in Revelation Biosciences in 2026 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

9% more funds holding

Funds holding: 11 → 12 (+1)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

0.4% less ownership

Funds ownership: 7.79% → 7.38% (-0.4%)

10% less capital inflows, than outflows

Capital inflows: $95.6K | Capital outflows: $106K

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
2
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

REVB Hedge Fund Activity: Q3 2026 in Review

12 of the 8,184 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences (REVB) for Q3 2026, worth a combined $241K — down 23% from $313K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new REVB positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $62.4K. The largest seller was Sabby Management, cutting an estimated $85.8K.

  • 12 institutional investors held Revelation Biosciences (REVB) as of Q3 2026, up from 11 in Q2 2026.
  • Funds reported $241K of Revelation Biosciences stock for Q3 2026, down 23% quarter-over-quarter.
  • 3 funds opened new Revelation Biosciences positions in Q3 2026 and 2 closed out, a net change of +1 holder.
  • The largest Revelation Biosciences buyer in Q3 2026 was Citadel Advisors, an estimated $62.4K added.
  • The largest Revelation Biosciences seller in Q3 2026 was Sabby Management, an estimated $85.8K sold.

Based on aggregated 13F filings for Q3 2026.